Dalu Davide

Antibody response to three-dose anti-SARS-CoV-2 mRNA-vaccination in treated solid cancer patients / D. Dalu, M. Tarkowski, L. Ruggieri, M.S. Cona, A. Gabrieli, D. De Francesco, C. Fasola, S. Ferrario, A. Gambaro, E. Masedu, G. Parma, E. Rulli, C. De Stradis, D. Mavilio, F. Calcaterra, F. Manoni, A. Riva, N. La Verde. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 1097-0215. - 154:8(2024 Apr 15), pp. 1371-1376. [10.1002/ijc.34817]

Cancer care in transgender and gender-diverse persons: results from two national surveys among providers and health service users by the Italian Association of Medical Oncology / A.G. Leone, R. Miceli, D. Trapani, M. Massagrande, F. Morano, S. Marsoni, N. La Verde, R. Berardi, R. Casolino, M. Lambertini, D. Dalu, M. Di Maio, G.D. Beretta, F. Perrone, S. Cinieri, F. Pietrantonio. - In: ESMO OPEN. - ISSN 2059-7029. - 8:3(2023), pp. 101578.1-101578.9. [10.1016/j.esmoop.2023.101578]

Single nucleotide polymorphisms to predict taxanes toxicities and effectiveness in cancer patients / S. Demurtas, N. La Verde, S. Rota, G. Casazza, C. Montrasio, S. Cheli, M.S. Cona, D. Dalu, C. Fasola, S. Ferrario, V. Filipazzi, A. Gambaro, N. Tosca, E. Clementi. - In: PHARMACOGENOMICS JOURNAL. - ISSN 1470-269X. - 21:4(2021), pp. 491-497. [10.1038/s41397-021-00227-7]

ABCB1 c.3435C > T polymorphism is associated with platinum toxicity: a preliminary study / B. De Troia, D. Dalu, V. Filipazzi, L. Isabella, N. Tosca, S. Ferrario, A.R. Gambaro, L. Somma, C. Fasola, S. Cheli, E. Clementi, D. De Francesco, F.S. Falvella, M.T. Cattaneo. - In: CANCER CHEMOTHERAPY AND PHARMACOLOGY. - ISSN 0344-5704. - 83:4(2019 Apr), pp. 803-808.

A targeted approach to genetic counseling in breast cancer patients: the experience of an Italian local project / N. La Verde, F. Corsi, A. Moretti, B. Peissel, D. Dalu, S. Girelli, C. Fasola, A. Gambaro, G. Roversi, J. Azzollini, P. Radice, V. Pensotti, G. Farina, S. Manoukian. - In: TUMORI. - ISSN 2038-2529. - 102:1(2016), pp. 45-50. [10.5301/tj.5000407]